By
Trending Posts
Can Yseop and Novartis Cut Drug Development Timelines…
Elite AI Partnership with NovartisYseop has been named among only seven elite AI partners by Novartis, aiming to…
Dyno Therapeutics Reveals Roche’s Decision to Exercise Option…
January 13, 2025 Dyno Therapeutics has announced that Roche has exercised its option to license a novel AAV…
NVIDIA Joins Forces with Industry Leaders to Revolutionize…
J.P. Morgan Healthcare Conference — Jan 13, 2025 At the J.P. Morgan Healthcare Conference, NVIDIA unveiled transformative partnerships…
Insilico Medicine Identifies Novel Endometriosis Targets and Repurposes…
FLORENCE, Italy & CAMBRIDGE, Mass.— Jan 10, 2025AI-Driven Research Unveils New Therapeutic Approaches Researchers have leveraged artificial intelligence…
XtalPi and UCB Partner to Advance AI-Powered Biologic…
Cambridge, MA – Jan 10 2025 XtalPi Inc. (HKEX: 2228.HK), a leader in AI-powered pharmaceutical technology, announced a…
Can AI-Powered Drug Discovery Redefine Cardiometabolic Treatment? Novo…
Key Takeaways for Industry Leaders A Landmark Expansion: 20 Programs, $4.6 Billion, and a Bold Vision for AI…
Recursion Advances AI-Powered Oncology Pipeline with REC-3565 and…
Salt Lake City – January 7, 2025 Recursion, a clinical-stage TechBio company pioneering the integration of artificial intelligence…
Pfizer Expands Deal to $610M, AI Drug Discovery…
Boston – Jan 7, 2025 Strengthening AI-Driven Innovation in Small Molecules and ADCs Pfizer has expanded its partnership…
Terray’s AI-Driven Drug Discovery Platform Secures Collaboration with…
Boston – Dec 17, 2024 Strategic Expansion Following $120M Series B Terray Therapeutics is closing the year with…
Trending Posts
Latest Stories
Can HekaBio and Alfresa’s AI-Driven Alliance Redefine Japan’s Biopharma Access and Launch Asia’s Next AI Commercialization Engine?
Smart Partnerships: HekaBio Leverages Alfresa’s Scale to Localize Global InnovationJapan’s historically delayed access to global…
China focus: Is AstraZeneca’s $5.3B AI-Powered Alliance with CSPC the New Gold Standard in Chronic Disease Drug Discovery?
Key Takeaways: AI as the Catalyst: CSPC’s Dual-Engine Platform Front and CenterAt the core of…
Can Ellipsis Health’s $45M Series A and Launch of ‘Sage’ Redefine AI-Driven Care Management in U.S. Healthcare?
Key Insights: Sage Redefines AI Care Management with Empathy at the CoreEllipsis Health is introducing…
How Tempus AI and Northwestern Use AI to Unlock the Genomic Code of Alzheimer’s? A New Collaboration Targets Precision Breakthroughs
Key Takeaways Transforming Alzheimer’s Research with AI and Precision GenomicsIn a multi-year collaboration announced today,…
Gallery
